Rheumatoid arthritis (RA) is a systemic autoimmune disease that predominantly affects the
joints. The prevalence of RA varies globally, with generally a higher prevalence in …

Background Rheumatoid arthritis (RA) is a chronic inflammatory disease that leads to a
significant social burden. East Asian herbal medicine (EAHM) has long been used to treat …

Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint inflammation that
involves symmetric polyarthritis of small and large joints. Autoimmune rheumatic diseases …

Interstitial lung disease (ILD) is a frequent complication of rheumatoid arthritis (RA) that is
associated with a significant increase in mortality. Several risk factors for the development of …

Objective To evaluate the associations of plasma matrix metalloproteinases (MMPs) with
prevalent and incident interstitial lung disease (ILD) in people with rheumatoid arthritis (RA) …

Background Nintedanib is a tyrosine kinase inhibitor used in the treatment of progressive
fibrosing interstitial lung diseases (ILDs). We assessed the safety and tolerability of …

Objectives To explore the course of lung function and RA disease activity and predictive
factors for deteriorating lung function in patients with RA-interstitial lung disease (ILD) …

Objective To investigate prevalence, incidence and medication of interstitial lung disease
(ILD) among German individuals with rheumatoid arthritis (RA). Methods Nationwide …

Objective Interstitial lung disease (ILD) is one of the commonest systemic complications in
patients with rheumatoid arthritis (RA) and carries a significant morbidity and mortality …

Objective To investigate the prevalence and mortality impact of interstitial lung abnormalities
(ILAs) in RA and non-RA comparators. Methods We analysed associations between ILAs …